NRX Pharmaceuticals Inc. (NASDAQ: NRXP)
$2.54
+0.1500 ( +6.28% ) 95.8K
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
Market Data
Open
$2.54
Previous close
$2.39
Volume
95.8K
Market cap
$26.75M
Day range
$2.37 - $2.54
52 week range
$1.90 - $7.33
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 14 | Jun 27, 2024 |
3 | Insider transactions | 1 | Jun 26, 2024 |
8-k | 8K-related | 15 | Jun 20, 2024 |
8-k | 8K-related | 15 | May 23, 2024 |
8-k | 8K-related | 17 | May 16, 2024 |
10-q | Quarterly Reports | 84 | May 14, 2024 |
8-k | 8K-related | 19 | Apr 30, 2024 |
10-k/a | Quarterly Reports | 17 | Apr 29, 2024 |
8-k | 8K-related | 21 | Apr 19, 2024 |
8-k | 8K-related | 16 | Apr 15, 2024 |